Single-use Bioprocessing Market Size, Share, and Trends

Single-Use Bioprocessing Market (By Product: Filtration Assemblies, Disposable Bioreactors, Disposable Mixers, Media Bags & Containers, and Others; By Application: Filtration, Purification, Cell Culture, and Others; By End User: Biopharmaceutical Manufacturers, Clinical & Academic Research Institutes, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 - 2030

  • Last Updated : October 2022
  • Report Code : 1308
  • Category : Healthcare

The global single-use bioprocessing market size was estimated at USD 25.44 billion in 2022 and is expected to hit USD 84.12 billion by 2030, poised to grow at a noteworthy CAGR of 16.1% from 2023 to 2030. U.S. single-use bioprocessing market was accounted at USD 6.7 billion in 2022.

Single-Use Bioprocessing Market Size 2021 to 2030

Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare

Key Takeaway:

  • North America has captured revenue share of 34.5% in 2022.
  • Asia Pacific region is anticipated to grow at CAGR of 16.5% over the forecast period 2023 to 2030.
  • By Product, the simple & peripheral elements segment has accounted 49.4% revenue share in 2022.
  • By Workflow, the upstream bioprocessing segment recorded revenue share of 57.8% in 2022.
  • By End-use, the biopharmaceutical manufacturers segment has held larghest revenue share of around 58.5% in 2022.
  • Academic & clinical research institutes segfment are expected to reach at a 16.37% of CAGR from 2023-2030.

Growth Factors

The single-use bioprocessing market is significantly driven by the growing demand from the biopharmaceutical industry. Majority of the biopharmaceutical companies are increasingly adopting the single-use bioprocessing technology because the single-use bioprocessing systems increases the efficiency in the process and reduces the costs associated with sterilization, cleaning, and maintenance of steel bioreactors. In biopharmaceutical, the single-use bioprocessing system is used in a wide range of applications such as storage, filtration, purification, and mixing. Moreover, the biopharmaceuticals is rapidly growing. The biopharmaceutical alone forms around 20% of the global pharma market. The extensive use of biopharmaceuticals as therapeutic agents like cell therapies, allergenic agents, and vaccines to name a few. It is also used in the treatment of cancer. Hence, the rapid growth of biopharmaceuticals is significantly boosting the demand for the single-use bioprocessing system.

The growing geriatric population across the globe is expected to fuel the market growth in the upcoming years. According to the United Nations, by 2050, it is estimated that around 1.5 billion of the global population will be of 65 years or above. The geriatric population are more prone to chronic diseases and hence the demand and consumption of biopharmaceutical medicines will rise extensively, thereby propelling the growth of the global single-use bioprocessing market.

Single-Use Bioprocessing Market Scope

Report Coverage Details
Market Size USD 84.12 Billion by 2030
Growth Rate CAGR of 16.1% From 2023 to 2030
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2030
Segments Covered Product, End User, Application, Workflow, Region
Companies Mentioned PBS Biotech, Inc., Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Entegris, Inc., Pall Corporation, Corning Incorporated, Eppendorf AG, Infors AG, General Electric Company (GE Healthcare), Lonza, Rentschler Biopharma SE

 

Product Insights

By product, the media bags and containers segment led the global single-use bioprocessing market with remarkable revenue share in 2022 and is anticipated to retain its dominance throughout the forecast period. The use of media bags and containers offers low investment, lower wastes emission, and lower operational costs in the biopharmaceutical industry. Moreover, the single-use media bags and containers offers temperature resistance along with durability. Therefore, the extensive use of media bags and containers in the biopharmaceuticals have augmented the segment growth in the recent years.

End User Insights

By end user, the biopharmaceutical manufacturers segment led the market in 2022 and the rapid growth of biopharmaceuticals industry is significantly boosting the growth of this segment. Moreover, more than 80% of the biopharmaceutical plants have adopted the single-use bioprocessing systems as this is cheaper, efficient, and reliable.

Single-Use Bioprocessing Market Share, By End Users, 2020 (%)

The extensive and increasing use of single-use or disposables by the contract manufacturers have augmented the segment growth. Furthermore, the increased demand for the single-use bioprocessing systems in various bioprocessing services is expected to foster the market growth in the foreseeable future.

Application Insights

By application, the filtration segment led the global single-use bioprocessing market with remarkable revenue share in 2022 and is anticipated to retain its dominance throughout the forecast period. This is attributed to the increasing adoption of single-use bioprocessing system in filtration owing to its efficient filtration even at large scale. It is used for bioburden reduction, polishing of biomolecules, and for ultrafiltration.

Regional Insights

Based on the region, the North America dominated the market in 2022 and is estimated to be the most opportunistic market. This is attributed to the rapid growth and development of biopharmaceutical industry in the region. Moreover, the outbreak of the COVID-19 pandemic stimulated the government to invest heavily in the research and development of the COVID-19 vaccines, diagnostics tests, and drugs. The US government sanctioned over US$ 480 million to Moderna, Inc., for the development of COVID-19 vaccines. The Canada government spent around US$ 160 million in 2020, towards the development of vaccines and drugs for COVID-19 treatment.

Single-Use Bioprocessing Market Share, By Region, 2020 (%)

The presence of giant players, largescale production units, growing adoption of disposables, increased expenditure in health care, and highly developed healthcare infrastructure are the top factors augmenting the North America single-use bioprocessing market. Moreover, the numerous contract manufacturers and the growing usage of disposables amongst them is exponentially driving the single-use bioprocessing market in the region.

The Asia Pacific has potential growth opportunities owing to the growing biopharmaceutical market in the nations such as China, Japan, and India. Moreover, rising investments by the biotechnology and pharmaceutical companies and the rapid growth of the contract manufacturers may lead to the emergence of Asia Pacific to be the manufacturing hub for the pharmaceuticals. Hence, the region may contribute significantly towards the growth of the single-use bioprocessing market in the forthcoming years.

Key Companies & Market Share Insights

The market is moderately fragmented with the presence of several local companies. These market players are striving to gain higher market share by adopting strategies, such as investments, partnerships, and acquisitions & mergers. Companies are also spending on the development of improvedand efficient solutions. Moreover, they are also focusing on maintaining competitive pricing.

In February 2020, MabPlex, a contract manufacturing company, launched two new cell culture production lines with 2000-liter disposable bioreactors. The various developmental strategies undertaken by key market players increases competition and contributes significantly towards the development of single-use bioprocessing market.

Single-Use Bioprocessing Market Companies

  • Thermo Fisher Scientific, Inc.
  • Sartorius AG
  • Merck KGaA
  • Pall Corporation
  • Corning Incorporated
  • Eppendorf AG
  • General Electric Company (GE Healthcare)
  • Lonza
  • Rentschler Biopharma SE
  • JM BioConnect
  • Meissner Filtration Products, Inc.
  • Infors AG
  • BoehringerIngelheim GmbH
  • Entegris, Inc.
  • PBS Biotech, Inc.

Segments Covered in the Report

By Product

  • Filtration Assemblies
  • Disposable Bioreactors
  • Disposable Mixers
  • Media Bags & Containers
  • Others

By Application

  • Filtration
  • Purification
  • Cell Culture
  • Others

By End User

  • Biopharmaceutical Manufacturers
  • Clinical & Academic Research Institutes
  • Others

By Workflow

  • Upstream
  • Fermentation
  • Downstream

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Frequently Asked Questions

According to Precedence Research, the global single-use bioprocessing market size was surpassed at USD 25.44 billion in 2022 and projected to reach USD 84.12 billion by 2030.

The global single-use bioprocessing market is expected to grow at a CAGR of 16.1% over the forecast period 2023 to 2030.

Rapid growth of the biopharmaceutical industry and growing government investments in the development of vaccines and drugs are the driving factors of the single-use bioprocessing market.

The major players in the single-use bioprocessing market are Thermo Fisher Scientific, Inc., Sartorius AG, Merck KGaA, Pall Corporation, Corning Incorporated, Eppendorf AG, General Electric Company (GE Healthcare), Lonza, Rentschler Biopharma SE

The North America region accounted the market with revenue share of 34% in 2020.

Based on product, the media bags and containers segment led the global single-use bioprocessing market.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Single-Use Bioprocessing Market, By Product

7.1. Single-Use Bioprocessing Market, by Product Type, 2021-2030

7.1.1. Filtration Assemblies

7.1.1.1. Market Revenue and Forecast (2019-2030)

7.1.2. Disposable Bioreactors

7.1.2.1. Market Revenue and Forecast (2019-2030)

7.1.3. Disposable Mixers

7.1.3.1. Market Revenue and Forecast (2019-2030)

7.1.4. Media Bags & Containers

7.1.4.1. Market Revenue and Forecast (2019-2030)

7.1.5. Others

7.1.5.1. Market Revenue and Forecast (2019-2030)

Chapter 8. Global Single-Use Bioprocessing Market, By Application

8.1. Single-Use Bioprocessing Market, by Application, 2021-2030

8.1.1. Filtration

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Purification

8.1.2.1. Market Revenue and Forecast (2019-2030)

8.1.3. Cell Culture

8.1.3.1. Market Revenue and Forecast (2019-2030)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Single-Use Bioprocessing Market, By End User Type 

9.1. Single-Use Bioprocessing Market, by End User Type, 2021-2030

9.1.1. Biopharmaceutical Manufacturers

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Clinical & Academic Research Institutes

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Single-Use Bioprocessing Market, By Workflow Type 

10.1. Single-Use Bioprocessing Market, by Workflow Type, 2021-2030

10.1.1. Upstream

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Fermentation

10.1.2.1. Market Revenue and Forecast (2019-2030)

10.1.3. Downstream

10.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Single-Use Bioprocessing Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.1.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.1.5. U.S.

11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.1.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.1.6. Rest of North America

11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.1.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.1.6.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.1.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.2.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.2.5. UK

11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.2.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.2.6. Germany

11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.6.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.2.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.2.7. France

11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.7.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.2.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.2.8. Rest of Europe

11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)

11.2.8.2. Market Revenue and Forecast, by Application (2019-2030)

11.2.8.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.2.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.3.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.3.5. India

11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.3.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.3.6. China

11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.6.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.3.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.3.7. Japan

11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.7.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.3.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.3.8. Rest of APAC

11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)

11.3.8.2. Market Revenue and Forecast, by Application (2019-2030)

11.3.8.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.3.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.4.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.4.5. GCC

11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.4.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.4.6. North Africa

11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.6.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.4.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.4.7. South Africa

11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.7.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.4.7.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.4.8. Rest of MEA

11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)

11.4.8.2. Market Revenue and Forecast, by Application (2019-2030)

11.4.8.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.4.8.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.5.5. Brazil

11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.5.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.5.5.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

11.5.6. Rest of LATAM

11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)

11.5.6.2. Market Revenue and Forecast, by Application (2019-2030)

11.5.6.3. Market Revenue and Forecast, by End User Type (2019-2030)

11.5.6.4. Market Revenue and Forecast, by Workflow Type (2019-2030)

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Sartorius AG

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Merck KGaA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Pall Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Corning Incorporated

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Eppendorf AG

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. General Electric Company (GE Healthcare)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Lonza

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Rentschler Biopharma SE

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. JM BioConnect

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. Meissner Filtration Products, Inc.

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client